How is disease progress in Friedreich's ataxia best measured? A study of four rating scales

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 4, 2007, Pages 411-413

  Fahey, M C ^a,b   Corben, L ^a   Collins, V ^a   Churchyard, A J ^b   Delatycki, Martin B ^a  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT;

ADOLESCENT; ADULT; ARTICLE; BARTHEL INDEX; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FRIEDREICH ATAXIA; FUNCTIONAL INDEPENDENCE MEASURE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY ANALYSIS; BIOASSAY; CLASSIFICATION; CLINICAL TRIAL; DAILY LIFE ACTIVITY; HOSPITALIZATION; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; CHILD; CLINICAL TRIALS; DISEASE PROGRESSION; ENDPOINT DETERMINATION; FEMALE; FRIEDREICH ATAXIA; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33947729814     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.096008     Document Type: Article

References (13)

1. Durr A, Cossee M, Agid Y, et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. New Engl J Med 1996;335:1169-75.
2. Voncken M, Ioannou P, Delatycki MB. Friedreich ataxia - update on pathogenesis and possible therapies. Neurogenetics 2004;5:1-8.
3. Hobart JC, Lamping DL, Freeman JA, et al. Evidence-based measurement: which disability scale for neurologic rehabilitation? Neurology 2001;57:639-44.
4. Subramony SH, May W, Lynch D, et al. Measuring Friedreich ataxia: interrater reliability of a neurologic rating scale. Neurology 2005;64:1261-2.
5. Trouillas P, Takayanagi T, Hallett M, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997;145:205-11.
6. Storey E, Tuck K, Hester R, et al. Inter-rater reliability of the International Cooperative Ataxia Rating Scale (ICARS). Mov Disord 2004;19:190-2.
7. Keith RA, Granger CV, Hamilton BB, et al. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil 1987;1:6-18.
8. Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol 1989;42:703-9.
9. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27:S178-89.
10. Fillo A, De Michele G, Cavalcanti F, et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet 1996;59:554-60.
11. Delatycki MB, Paris DB, Gardner RJ, et al. Clinical and genetic study of Friedreich ataxia in an Australian population. Am J Med Genet 1999;87:168-74.
12. Schmitz-Hubsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006;66:1717-20.
13. Lynch DR, Farmer JM, Wilson RL, et al. Performance measures in Friedreich ataxia: potential utility as clinical outcome tools. Mov Disord 2005;20:777-82.